Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2010/091/001368
CTRI/2010/091/001368
Completed
Phase 3

A randomized, open label, comparative, multicentric study to assess the efficacy and safety of Acrivastine capsules in comparison with Chlorpheniramine maleate tablets in patients suffering from allergic rhinitis

Cadila Healthcare Ltd0 sites200 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Allergic rhinitisHealth Condition 2: J309- Allergic rhinitis, unspecified

Overview

Phase
Phase 3
Status
Completed
Enrollment
200
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients of either sex of 18 to 65 years of age
  • •2\.Established diagnosis of allergic rhinitis
  • •3\.Informed consent

Exclusion Criteria

  • •1\.Pregnancy \& Lactation.
  • •2\.Significant renal impairment.
  • •3\.Narrow\-angle glaucoma, GI or GUT obstruction.
  • •4\.Patients with acute attack of bronchial asthma or those on corticosteroids.
  • •5\.Nasal structural abnormalities
  • •6\.Upper respiratory tract infection
  • •7\.Hypersensitivity to study medications
  • •8\.Patients with any other serious concurrent illness or malignancy
  • •9\.Continuing history of alcohol and / or drug abuse
  • •10\.Recent participation in another clinical trial

Investigators

Similar Trials

Completed
Phase 3
A clinical trial to study the effects of two drugs, fixed dose combination capsules of Celecoxib and Diacerein and fixed dose combination tablets of Aceclofenac and Diacerein in patients with osteoarthritis of knee and/or hip joints.Health Condition 1: M169- Osteoarthritis of hip, unspecifiedHealth Condition 2: null- Osteoarthritis of knee and/or hip jointsHealth Condition 3: M179- Osteoarthritis of knee, unspecified
CTRI/2010/091/000053Cadila Healthcare Ltd200
Completed
Phase 3
A clinical trial to study effectiveness and safety of Fixed dose combination tablets of Hyoscine butylbromide & Mefenamic acid in patients suffering from paroxysmal spastic abdominal paiHealth Condition 1: R108- Other abdominal painHealth Condition 2: null- Paroxysmal spastic abdominal pain
CTRI/2011/091/000141Cadila Healthcare Ltd200
Completed
Phase 3
A clinical trial to study to assess effectiveness and safety of two medications for the treatment for schizophrenia
CTRI/2011/091/000140Cadila Healthcare Ltd200
Unknown
Phase 4
To determine the efficacy and safety of a combination of Extended Release (ER) Niacin and Rosuvastatin as compared with Rosuvastatin alone in patients with Mixed Dyslipidemia.Health Condition 1: null- Mixed Dyslipidemia
CTRI/2010/091/003016Troikaa Pharmaceuticals Ltd160
Completed
Phase 3
A clinical trial to study effectiveness and safety of Revaprazan tablets in comparison with Omeprazole capsules in patients suffering from Peptic Ulcer or Acute Gastritis
CTRI/2010/091/001055Cadila Healthcare Ltd200